Liver-Directed Therapies Enhance Treatment Landscape for Metastatic NETs

Tony Berberabe, MPH @OncBiz_Wiz
Published: Wednesday, Oct 09, 2019
Juan C. Camacho, MD, assistant attending radiologist in the Department of Radiology of Memorial Sloan Kettering Cancer Center

Juan C. Camacho, MD

Patients with neuroendocrine tumors (NETs) that have metastasized to the liver derive clinical benefit from locoregional therapies, but treatment guidelines for employing these strategies must be more fully developed, according to Juan C. Camacho, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Navigating Treatment Decisions in mCRC: Sequencing Through Multiple Lines of CareMar 26, 20201.5
Community Practice Connections™: Optimizing Care in the Era of an Expanding Armamentarium for Hepatocellular CarcinomaMar 29, 20202.0
Publication Bottom Border
Border Publication